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Samuel Butler, novelist (1835e1902)
Many of you are already well acquainted with the
procedure known as vertebroplasty, which has become
a significant contributor to the management of both osteo-
porotic and malignant compression fractures. Under imaging
guidance, a needle is placed within the collapsed vertebrae
and acrylic orthopaedic bone cement is injected. The vast
majority of patients with osteoporotic fractures (>90%)
report significant and durable pain relief at the treated levels.
The procedure was first devised in France in the mid 1980s
and by the late 1990s had become widely used not only
throughout Western Europe but North America and other
parts of the world. Hundreds of thousands of these proce-
dures have been performed, and interventional radiologists
who perform vertebroplasty acknowledge that it is one of the
most effective and dramatically satisfying procedures they
perform. Because of the improvement in patient pain and its
excellent safety profile, this procedure has become widely
adopted.
However, it has been recognized that the accrued expe-
rience with vertebroplasty has not included a double-blinded
randomized control trial to document efficacy. In the current
evidence-based environment of modern medicine, this deficit
must be addressed. It is noted that several practical barriers
exist to performing a randomized trial of this procedure. The
most problematic barrier is a historical one, secondary to the
rapid acceptance of this procedure by not only interventional
radiologists, referring clinicians, and patients, but by many
third-party payers who saw it as a way of quickly resolving
an often difficult medical problem. In spite of these issues, 2
double-blind randomized trials were recently published in
the New England Journal of Medicine [1,2]. Consistent with
this rigorous study design, both trials compared verte-
broplasty in the treatment arm with a sham procedure that
mimicked vertebroplasty on the nontreatment arm, with
random allocation to either arm. Consent for the trial was
performed before allocation, with the result that prospective
volunteers have only a 50% chance of receiving verte-0846-5371/$ - see front matter  2009 Canadian Association of Radiologists.
doi:10.1016/j.carj.2009.08.001broplasty. As expected, patient accrual in both trials was
extremely limited, taking 5 and 4 years, respectively, in large
part, because many patients were unwilling to undergo
randomization. The published conclusions of these trials
indicate that patients in the vertebroplasty arm did no better
than those in the sham treatment arm and that vertebroplasty
‘‘does not work.’’
Several problems exist with these articles. First, these 2
trials sample fewer than 300 patients in both treatment and
nontreatment arms. The small size of the sample is in large
part because of the difficulty in having patients accept
randomization. Patients in severe pain are often unwilling to
undergo randomization if they perceive that a safe, fast, and
purportedly highly effective treatment exists. The effect of
this preselection is to remove those patients in greatest pain,
which serves to decrease the measured treatment effect and
measured efficacy of vertebroplasty. In spite of this limita-
tion, if we look at the data carefully, in both trials, there was
a statistical trend (that did not, however, reach statistical
significance) that suggested that vertebroplasty may be more
effective than the sham treatment. It is conceivable that, with
a larger sample, vertebroplasty may be shown to be effective
even in this less symptomatic cohort.
The implications of basing management decisions on
these trials are significant. This would mean rejection of
what has come to be thought of as one of the most effective
and safe treatments for severely painful compression frac-
tures in osteoporosis, a widespread condition that is
becoming increasingly significant as the population ages.
Because of this, it is very important that these 2 trials be
examined critically to determine whether they indeed should
be accepted at face value or whether further investigation is
truly merited. The investigators admit that they had origi-
nally planned to recruit more patients; however, this was
changed midstream through the trial when it was decided to
accept a smaller number. The fact that a smaller number of
patients was studied also raises another difficulty in the
analysis of these trials. Different types of compression
fractures exist, and it is quite possible that these different
categories of compression fracture will respond to verte-
broplasty in different ways. Much of the data suggests that
patients with fracture planes (so called clefts) are more likelyAll rights reserved.
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trial makes it impossible to analyse for fracture subtypes.
Because of these limitations, many interventional radiolo-
gists believed that these conclusions are premature and
indeed are rather unlikely to be substantiated by detailed and
larger trials. For this reason, vertebroplasty should continue
to be performed while accruing additional data to ensure that
many patients who are in significant pain are not denied
a potentially highly effective and safe treatment.
So Why Is This Controversy of Significance to
Radiologists in General?
These studies outline the importance of study design and
careful interpretation of the results. The investigators of both
of these trials had an extremely challenging, very difficult
question to answer, with many barriers put in front of them.
They did a remarkable job in trying to overcome these
difficulties and have provided thought-provoking and useful
data. However, because of the limitations outlined above, we
do not believe that these 2 trials can be viewed as the final
word on this subject. We believe that further research on theclinical efficacy of vertebroplasty is indicated to provide
stronger evidence.
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